Johnson & Johnson Share Buybacks increased by 109.4% to $4.03B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 89.4%, from $2.13B to $4.03B. Over 4 years (FY 2021 to FY 2025), Share Buybacks shows an upward trend with a 14.6% CAGR.
High repurchases often signal management's confidence in the company's valuation or a strategy to improve earnings per share.
The cash outflow associated with the company buying back its own shares from the open market. This is a primary method f...
Common among mature, cash-generative companies; peers in the healthcare sector often balance this with R&D investment.
share_repurchases| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $631.00M | $391.00M | $996.00M | $1.58B | $973.00M | $2.17B | $1.32B | $3.54B | $381.00M | $920.00M | $216.00M | $1.48B | $136.00M | $539.00M | $282.00M | $2.13B | $0.00 | $1.90B | $1.92B | $4.03B |
| QoQ Change | — | -38.0% | +154.7% | +58.3% | -38.3% | +122.5% | -39.0% | +168.0% | -89.2% | +141.5% | -76.5% | +582.9% | -90.8% | +296.3% | -47.7% | +654.3% | -100.0% | — | +1.2% | +109.4% |
| YoY Change | — | — | — | — | +54.2% | +453.7% | +32.5% | +124.3% | -60.8% | -57.5% | -83.6% | -58.3% | -64.3% | -41.4% | +30.6% | +44.2% | -100.0% | +252.9% | +582.3% | +89.4% |